Skip to content

Dortmund, 8th September 2025

Susmita Ghosh, a doctoral student in the Biofluorescence Research Group, is one of three lead authors of a study published in the Journal of Neuroinflammation. Together with Ali Ata Tuz (ISAS and Universitätsklinikum Essen and Laura Karsch (Universitätsklinikum Essen), she investigated the connection between gut microbiota and neutrophil granulocytes. In this interview, the biologist discusses her research on proteins and the effect that neutrophils have on the brain following a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Susmita Ghosh analyses samples of neutrophil granulocytes using an ultrasensitive mass spectrometer. Her aim is to understand how immune cells behave after a stroke.

© ISAS / Hannes Woidich

1. How did you come up with the link between gut microbiota, neutrophile activation and strokes?

Ghosh: In our previous papers, we observed that activated neutrophils have a negative impact on stroke outcomes. We wanted to find out why and identify the decisive factors. Meanwhile, Dr Vikramjeet Singh from University Hospital Essen was researching the link between gut microbiota and stroke outcomes. Together, we wanted to establish whether gut microbiota could trigger neutrophil activation upon stroke. To do this, Ali Tuz, Laura Karsch and I divided the parts of the study equally. While Ali and Laura brought in their expertise with imaging and flow cytometry techniques, I was responsible for the proteomic analyses using liquid chromatography-mass spectrometry (LC-MS). Since the neutrophils’ behaviour depends on their protein expression, we chose proteomic analysis to understand the neutrophiles’ behaviour after a stroke. From the brain of mice with stroke, we got only a handful of neutrophils, which is difficult for proteome analyses. Since I had already optimised the proteomics approach for low input samples in a previous study, it was easy to apply this method to investigate the gut microbiota’s influence on neutrophils.

2. What exactly did your results reveal about gut microbiota and neutrophile activation?

Ghosh: I analysed the proteome of neutrophils isolated from the brains and blood of mice that had experienced a stroke. Using label-free quantitative proteomics, I identified the changes in protein expression between neutrophils upon microbiota depletion compared to the control sample in which microbiota was present. This enabled us to infer that neutrophils from mice with depleted microbiota were less activated and provided greater support for tissue repair in the brain following a stroke. This finding indicates that gut microbes positively influence neutrophil activation after stroke, causing more and worsening existing inflammation. We were able to validate my results with those from other experiments, using ELISA (Enzyme-linked Immunosorbent Assay). This was important to us, as validating proteomic data is difficult and often missing in research papers.

Article Recommendation

Tuz, A. A., Ghosh, S., Karsch, L., Antler, M., Lakovic, V., Lohmann, S., Lehmann, A. H., Beer, A., Nagel, D., Jung, M., Hörenbaum, N., Kaygusuz, V., Qefalia, A., Alshaar, B., Amookazemi, N., Bolsega, S., Basic, M., Siveke, J. T., Heiles, S., Grüneboom, A., Lueong, S., Herz, J., Sickmann, A., Hagemann, N., Hasenberg, A., Hermann, D. M., Gunzer, M., Singh, V.

(2025) Gut microbiota deficiency reduces neutrophil activation and is protective after ischemic stroke. Journal of Neuroinflammation, 22, Nr. 137.

https://doi.org/10.1186/s12974-025-03448-w

3. How do your findings about the gut microbiota contribute to our understanding of its role after stroke, and what are the next steps in this line of research?

Ghosh: The gut microbiota is essential for our day-to-day life. However, our results suggest that healthy microbiota can have a negative influence on stroke outcomes due to activated neutrophils. But we still do not know how this microbiota-neutrophil-interaction occurs. If we manage to identify any factor that activates the neutrophils, we could try to inhibit it to reduce tissue damage. However, we also do not yet know if our findings apply to human gut microbiota. This is an exciting area of research with many questions still to be answered.

(The interview was conducted by Anna Becker.)

Share

Further articles

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.

What are you doing at ISAS, Kevin?

What changes take place in heart muscle cells when a left ventricular assist device is used? ISAS doctoral student Kevin Hau (28) is tackling this question by researching the consequences of heart attacks using various omics analyses.

Kevin Hau is wearing a white coat bearing the ISAS logo. He is standing next to a microscope in a laboratory. In the lower left corner of the image, a computer screen can be seen. Open on the monitor is a microscopic image of reddish tissue.

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.

PODCAST »NACHGEFORSCHT – DIE LIVESCHALTE INS LABOR« Episode 12: Less Is More, at Least When It Comes to the Number of Cells

PhD student Susmita Ghosh talks about her research on neutrophil granulocytes – tiny immune cells that play a role in both defending the body against infections and inflammatory processes. Instead of working with countless cells, the biologist optimises analytical methods to enable meaningful proteome analyses with an extremely small number of cells. Ghosh explains why ‘less is more’ and what this has to do with modern mass spectrometry in episode 12 of the podcast.

What are you doing at ISAS, Nora?

Nora Pauly is writing her doctoral thesis on the consequences of heart attacks at the joint graduate college of Essen University Hospital and ISAS. With the bed-to-bench-to-bed principle, her work in basic research is closely linked to the everyday clinical practice of caring for heart attack patients.

New Framework for Efficient Image Data Analysis in Biomedicine

How can AI be used optimally in bioimaging research? A team of international researchers and scientists led by Dr Jianxu Chen from ISAS has developed a framework designed to make it easier for biomedical scientists to work with data-centric AI. Using the example of vascular segmentation, the authors of the publication in the journal npj imaging now demonstrate the advantages of the new framework.